John B. Henneman's most recent trade in Aprea Therapeutics Inc was a trade of 4,185 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 1,045 | 10,229 (0%) | 0% | 0 | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Nov 2024 | 515,715 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 14.30 per share. | 19 Nov 2024 | 87,765 | 0 (0%) | 0% | 14.3 | 1,255,040 | Common Stock |
| Anika Therapeutics Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 5,771 | 35,707 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 4,185 | 4,185 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 1,045 | 9,184 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 12.87 per share. | 18 Jun 2024 | 15,152 | 63,914 (0%) | 0% | 12.9 | 195,006 | Common Stock |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 15,651 | 87,765 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Purchase of securities on an exchange or from another person at price $ 7.29 per share. | 13 Mar 2024 | 6,860 | 8,139 (0%) | 0% | 7.3 | 50,009 | Common Stock |
| Aprea Therapeutics Inc | John B. Henneman | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2024 | 3,430 | 3,430 | - | - | Tranche A Warrant | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Mar 2024 | 3,430 | 3,430 | - | - | Tranche B Warrant | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 2,000 | 2,000 | - | - | Stock Options (Right to Buy) | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Aug 2023 | 500 | 1,279 (0%) | 0% | 0 | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 50,000 | 355,111 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale of securities on an exchange or to another person at price $ 17.17 per share. | 08 Aug 2023 | 50,000 | 72,114 (0%) | 0% | 17.2 | 858,650 | Common Stock |
| R1 RCM Inc. | John B. Henneman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.61 per share. | 08 Aug 2023 | 50,000 | 122,114 (0%) | 0% | 2.6 | 130,500 | Common Stock |
| Anika Therapeutics Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,500 | 29,936 (0%) | 0% | 0 | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 11,324 | 72,114 (0%) | 0% | 0 | Common Stock | |
| Orthofix Medical Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 14,354 | 48,762 (0%) | 0% | 0 | Common Stock | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 29,575 | 29,575 | - | - | Stock Option (right to Buy) | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jul 2022 | 5,995 | 15,605 (0%) | 0% | 0 | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 405,111 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 405,111 | 405,111 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 60,790 | 60,790 (0%) | 0% | - | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 54,751 | 0 (0%) | 0% | - | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 30,813 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 30,813 | 30,813 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 15,385 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 15,385 | 15,385 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 14,098 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 14,098 | 14,098 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 13,762 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 13,762 | 13,762 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 12,048 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 12,048 | 12,048 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 10,512 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 10,512 | 10,512 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 9,678 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 9,678 | 9,678 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 9,169 | 9,169 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 9,169 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 7,697 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 7,697 | 7,697 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 6,039 | 0 | - | - | Restricted Stock Units | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 4,770 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 4,770 | 4,770 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 4,542 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 4,542 | 4,542 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 4,285 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 4,285 | 4,285 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 4,025 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 4,025 | 4,025 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 3,871 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 3,871 | 3,871 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 3,684 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 3,684 | 3,684 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 3,319 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 3,319 | 3,319 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 3,249 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 3,249 | 3,249 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 2,851 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 2,851 | 2,851 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 2,846 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 2,846 | 2,846 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 2,186 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 2,186 | 2,186 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 1,965 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 1,965 | 1,965 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 1,660 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 1,660 | 1,660 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 1,649 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 1,649 | 1,649 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 1,625 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 1,625 | 1,625 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 1,490 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 1,490 | 1,490 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 21 Jun 2022 | 1,424 | 0 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 1,424 | 1,424 | - | - | Director Stock Option (right to buy) | |
| Anika Therapeutics Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2022 | 7,954 | 23,436 (0%) | 0% | 0 | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 6,039 | 6,039 | - | - | Restricted Stock Units | |
| R1 RCM Inc. | John B. Henneman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 5,151 | 0 | - | - | Restricted Stock Units | |
| R1 RCM Inc. | John B. Henneman | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2022 | 5,151 | 54,751 (0%) | 0% | - | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 1,965 | 1,965 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 1,424 | 1,424 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 1,649 | 1,649 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2021 | 1,660 | 1,660 | - | - | Director Stock Option (right to buy) | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 22,750 | 22,750 | - | - | Stock Option (Right to Buy) | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 4,610 | 9,610 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 4,172 | 15,482 (0%) | 0% | 0 | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 5,151 | 5,151 | - | - | Restricted Stock Units | |
| Anika Therapeutics Inc. | John B. Henneman | Director | Purchase of securities on an exchange or from another person at price $ 42.86 per share. | 18 May 2021 | 2,000 | 11,310 (0%) | 0% | 42.9 | 85,720 | Common Stock |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 1,490 | 1,490 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2021 | 1,625 | 1,625 | - | - | Director Stock Option (right to buy) | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 2,186 | 2,186 | - | - | Director Stock Option (right to buy) | |
| Anika Therapeutics Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2020 | 9,310 | 9,310 (0%) | 0% | 0 | Common Stock | |
| R1 RCM Inc. | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 3,249 | 3,249 | - | - | Director Stock Option (right to buy) | |
| Aprea Therapeutics Inc | John B. Henneman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2020 | 5,600 | 5,600 | - | - | Stock Option (right to Buy) |